DFCM
RLAY icon

Dark Forest Capital Management’s Relay Therapeutics RLAY Stock Holding History

Dark Forest Capital Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-405,995
Closed -$1.06M – 1469
2025
Q1 		$1.06M Buy
+405,995
New +$1.59M 0.05% 665
2023
Q1 		– Sell
-69
Closed -$1.03K – 1435
2022
Q4 		$1.03K Buy
+69
New +$1.32K ﹤0.01% 987
2022
Q3 		– Sell
-577
Closed -$10K – 1394
2022
Q2 		$10K Buy
+577
New +$12.4K ﹤0.01% 531
2022
Q1 		– Sell
-453
Closed -$14K – 1686
2021
Q4 		$14K Sell
453
-3,782
-89% -$120K 0.01% 810
2021
Q3 		$134K Buy
4,235
+4,205
+14,017% +$142K 0.05% 314
2021
Q2 		$1K Buy
+30
New +$989 ﹤0.01% 790

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dark Forest Capital Management's RLAY Position: Q2 2025 in Review

Dark Forest Capital Management sold out of Relay Therapeutics (RLAY) in Q2 2025, closing a stake of 405,995 shares — an estimated $1.06M sold.

Dark Forest Capital Management first reported a position in RLAY in Q2 2021 and held it in 6 quarters. The position peaked at $1.06M in Q1 2025. 208 funds tracked by Wall St. Rank hold RLAY as of Q2 2025.

  • Dark Forest Capital Management reported no remaining Relay Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Dark Forest Capital Management sold 405,995 Relay Therapeutics shares in Q2 2025, an estimated $1.06M.
  • Dark Forest Capital Management first reported a position in Relay Therapeutics in Q2 2021 and held it in 6 quarters.
  • Dark Forest Capital Management's Relay Therapeutics position peaked at $1.06M in Q1 2025.
  • 208 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2025.

Based on Dark Forest Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.